VMD
Viemed Healthcare, Inc. NASDAQ$9.48
Mkt Cap $364.8M
52w Low $5.93
83.5% of range
52w High $10.18
50d MA $9.31
200d MA $7.58
P/E (TTM)
26.2x
EV/EBITDA
5.8x
P/B
2.7x
Debt/Equity
0.1x
ROE
10.5%
P/FCF
24.2x
RSI (14)
—
ATR (14)
—
Beta
1.16
50d MA
$9.31
200d MA
$7.58
Avg Volume
284.4K
About
Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and …
Recent Earnings
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | 1M% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | AMC | 0.12 | 0.14 | +16.7% | 9.08 | -11.8% | -7.5% | -3.3% | +2.3% | +4.6% | +0.0% | +7.5% | — |
| Nov 5, 2025 | AMC | 0.09 | 0.09 | +0.0% | 6.43 | -2.0% | -2.6% | -0.9% | -0.6% | -1.2% | +1.9% | +5.3% | — |
| Aug 6, 2025 | AMC | 0.09 | 0.08 | -5.9% | 6.45 | +4.8% | +7.9% | +10.1% | +13.0% | +15.3% | +13.6% | +6.7% | — |
| May 7, 2025 | AMC | 0.06 | 0.06 | +0.0% | 7.27 | +0.0% | -11.7% | -13.1% | -10.5% | -5.2% | -5.5% | -7.6% | — |
| Mar 10, 2025 | AMC | 0.11 | 0.10 | -9.1% | 7.40 | +0.0% | +5.4% | +5.5% | +4.2% | +2.3% | +0.1% | -10.1% | — |
| Nov 6, 2024 | AMC | 0.08 | 0.10 | +25.0% | 9.14 | +5.5% | -1.5% | -0.8% | +4.0% | +2.8% | +0.1% | -5.7% | — |
| Aug 7, 2024 | AMC | 0.07 | 0.04 | -42.9% | 6.53 | -2.0% | +10.0% | +11.2% | +8.1% | +8.6% | +8.6% | +12.3% | — |
| May 6, 2024 | AMC | 0.07 | 0.04 | -42.9% | 8.22 | -0.2% | -6.8% | -11.6% | -13.3% | -13.0% | -14.2% | -8.2% | — |
| Mar 6, 2024 | AMC | 0.10 | 0.09 | -10.0% | 9.38 | +1.9% | +6.5% | +5.7% | -0.4% | +1.1% | +1.1% | -9.4% | — |
| Nov 1, 2023 | AMC | 0.09 | 0.07 | -22.2% | 6.07 | -0.7% | +12.0% | +23.2% | +15.8% | +17.0% | +14.3% | +26.2% | — |
Recent Analyst Ratings
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 3 | RBC Capital | Maintains | Outperform → Outperform | — | $5.64 | $5.61 | -0.5% | +3.2% | +1.1% | +7.8% | +7.6% | +7.8% |
| Mar 5 | RBC Capital | Maintains | Outperform → Outperform | — | $9.70 | $9.81 | +1.1% | -1.1% | -0.9% | +3.8% | +2.6% | +6.7% |
Recent Filings
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Viemed disclosed an investor presentation in March 2026, suggesting potential strategic announcements or capital allocation plans that could significantly impact shareholder value or market perception.
Mar 16
8-K · 8.01
!! High
Viemed Healthcare, Inc. Common Shares -- 8-K 8.01: Material Event / Announcement
Viemed Healthcare's material announcement has been incorporated into its 8-K filing, though the specific details require reviewing the attached press release exhibit for investor impact assessment.
Mar 4
Data updated apr 27, 2026 7:54am
· Source: massive.com